Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category
Stocks
from Market News Video
OncoGenex to Initiate Rainier Clinical Trial Evaluating OGX-427 with ABRAXANE plus Gemcitabine
May 01, 2013
Stocks Hitting 52-Week Lows
April 09, 2013
OncoGenex (OGXI) CFO Burns Resigns; Has 'Developing Relationship' with CEO Cormack
February 04, 2013
6 Biotechnology Stocks to Sell Now
January 23, 2013
Small is beautiful, tiny is even better
January 02, 2013
from MarketWatch
OncoGenex Announces Initiation of Randomized Phase 2 "PACIFIC" Study of OGX-427 in Combo with Zytiga
December 19, 2012
OncoGenex (OGXI) Commences OGX-427 Phase 2 in CRPC
December 19, 2012
5 Biotechnology Stocks to Sell Now
November 14, 2012
OncoGenex Pharmaceuticals, Inc. (OGXI) Tops Q3 EPS by 9c
November 08, 2012
OncoGenex Pharma (OGXI) Files $100M Mixed Shelf
November 08, 2012
Trading Radar for 11/08: Disney (DIS), Lannett (LCI), Allscripts (MDRX), Wendy's (WEN) Report
November 07, 2012
5 Biotechnology Stocks to Sell Now
November 07, 2012
OncoGenex (OGXI) gain on test study
November 06, 2012
Normal 0 false false false MicrosoftInternetExplorer4 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) shares took on 0.5% to $12.17, after it announced the completion of patient enrollment in the... Read More
from BAYSTREET RSS FEED
OncoGenex Pharmaceuticals, Inc. is Now Oversold (OGXI)
October 22, 2012
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category
Stocks
from Market News Video
OncoGenex (OGXI) Initiates Custirsen Phase 3 for NSCLC
September 27, 2012
3 Biotechnology Stocks to Buy Now
September 12, 2012
3 Biotechnology Stocks to Buy Now
September 12, 2012
Biotech Keeps Hitting the Mark
August 06, 2012
In this sometimes dangerously volatile corner of the health-care sector, one company is punching the clock with consistency, writes MoneyShow's Jim Jubak , also of Jubak's Picks . Read More
from MoneyShow.com
Needham & Company Maintains a 'Buy' on OncoGenex Pharmaceuticals (OGXI); Custersin and OGX-427 Development Remain on Track
August 03, 2012
Swing for the Fences With These 5 Biotech Stocks
July 16, 2012
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here